The multidimensional analysis of the clinical microarray datasets and comparative study of distinct breast cancer mouse models suggested GFAT and HAS2 co-expression in malignant breast cancer, which prompted us to examine whether the coordinated action of these enzymes was crucial for regulating CSC-like features. Here, HAS2 is linked to breast carcinoma.